Boston Scientific

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Boston Scientific

Mapping and Ablation
Transseptal Access Cardiac Ablation Solutions RF Cardiac Ablation Cardiac Mapping Cryo Cardiac Ablation Pulsed Field Ablation
Venous Therapies
EKOS Chronic Venous Obstruction Vein Treatment
Cardiac Rhythm Management
Structural Heart
TAVR Solutions Cerebral Embolic Protection Transseptal Access
Interventional Oncology
Drug-Eluting Technologies
Coronary

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

0:00

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

10 seconds

Playback speed

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

Who Should Receive Cerebral Embolic Protection

By Boston Scientific FEATURING David Rose, Hemal Gada

183 views

December 18, 2020

This is video #7 of a 7 part series on Cerebral Embolic Protection for Ischemic Stroke.

In this recorded interactive Q&A session from the SENTINEL Therapy Awareness webinar, Drs. Hemal Gada and David Rose answer questions on device deployment, patient selection, and the PROTECTED TAVR clinical trial.

Comments 0

Structural Heart